An in-depth look to KYONGBO PHARMACEUTICAL CO., LTD. operating, investing, and financing activities

214390 free cash flow for Q3 24 is -4.72 B KRW. For 2023, 214390 free cash flow was -4.85 B KRW and operating cash flow was 4.84 B KRW.